Trial record 1 of 64 for:    pompe disease
Previous Study | Return to List | Next Study

Safety Study of Recombinant Adeno-Associated Virus Acid Alpha-Glucosidase to Treat Pompe Disease

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Florida
ClinicalTrials.gov Identifier:
NCT00976352
First received: July 13, 2009
Last updated: June 24, 2014
Last verified: June 2014